These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3526054)

  • 1. Activities of cefoxitin in vitro and in vivo: a study in patients with biliary tract infection undergoing percutaneous transhepatic biliary drainage.
    Masuda G; Tabata I; Isawa T; Yamazaki E; Mizuoka K
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):367-72. PubMed ID: 3526054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD.
    Yu H; Guo Z; Xing W; Guo X; Liu F; Li B
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1136-44. PubMed ID: 21904809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infections of the biliary tract. Usefulness of bile culture in surgical environment].
    Pagano A; Pontello M; Di Paoli M
    Arch Sci Med (Torino); 1983; 140(1):67-76. PubMed ID: 6409053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decisive period in cefoxitin prophylaxis of experimental synergistic wound infection produced by Bacteroides fragilis and Escherichia coli.
    Shapiro M; Sacks T
    Isr J Med Sci; 1982 Aug; 18(8):863-5. PubMed ID: 6749759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotetan versus cefoxitin in the treatment of patients with biliary sepsis assessed by a biliary sepsis score.
    Basoli A; Schietroma M; Fiocca F; Vigliardi G; Speranza V
    Chemioterapia; 1988 Aug; 7(4):237-40. PubMed ID: 3180303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological characteristics of patients with biliary disease.
    Gu XX; Zhang MP; Zhao YF; Huang GM
    World J Gastroenterol; 2020 Apr; 26(14):1638-1646. PubMed ID: 32327912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infectious hepatobiliary diseases].
    Kunii O
    Naika; 1972; 29(2):215-21. PubMed ID: 4552440
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bacteriological aspects of biliary tract diseases].
    Ulrich C
    Ned Tijdschr Geneeskd; 1981 Jan; 125(5):187-90. PubMed ID: 7010187
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
    Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
    Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of bile tract infections, with special reference to diffusion of sodium cephalothin into bile (author's transl)].
    Masumoto T; Nozawa M; Masuoka S; Uehara Y; Nishimoto M
    Jpn J Antibiot; 1977 Sep; 30(9):657-61. PubMed ID: 335105
    [No Abstract]   [Full Text] [Related]  

  • 13. Route of infection in extrahepatic biliary tract disease. II: Bacterial recovery from gallbladder bile and gallbladder wall in human biliary tract disease.
    Nielsen ML; Justesen T
    Scand J Gastroenterol Suppl; 1976; 37():17-21. PubMed ID: 1064133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Salmonella enterica serovar typhi in bile and stool of patients with biliary diseases and those requiring biliary drainage for other purposes.
    Vaishnavi C; Singh S; Kochhar R; Bhasin D; Singh G; Singh K
    Jpn J Infect Dis; 2005 Dec; 58(6):363-5. PubMed ID: 16377868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of cefuzonam in biliary infection].
    Nakagawa K; Owada Y; Ouchi K
    Jpn J Antibiot; 1987 Feb; 40(2):460-8. PubMed ID: 3599394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative percutaneous transhepatic gallbladder drainage of gallbladder empyema before laparoscopic cholecystectomy.
    Tseng LJ; Tsai CC; Mo LR; Lin RC; Kuo JY; Chang KK; Jao YT
    Hepatogastroenterology; 2000; 47(34):932-6. PubMed ID: 11020851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of cefoxitin in surgery].
    Namatame K; Sato Y; Kiyoto K; Kurihara H; Oyama I; Ikari J; Watanabe H
    Jpn J Antibiot; 1983 Jun; 36(6):1553-61. PubMed ID: 6361315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbiological aspects of the elaboration of effective antibiotic therapy of bacterial lesions of the biliary tract].
    Sytnik IA
    Antibiotiki; 1984 Feb; 29(2):95-9. PubMed ID: 6703669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bacteria and biliary tract diseases.
    Singh Z; Wani NA; Misgar MS; Rashid PA
    Int Surg; 1977 Oct; 62(10):564-5. PubMed ID: 591228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of test for antibody-coated bacteria in biliary tract infection.
    Iwata K; Komatsu T; Watanabe M; Nishiya H; Kunii O
    Jpn J Exp Med; 1983 Feb; 53(1):59-63. PubMed ID: 6348352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.